Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

RBNZ Leaves OCR Unchanged At 2.50%

4/25/2012 7:15 PM ET

The Reserve Bank of New Zealand left its benchmark interest rate unchanged at 2.50 percent on Thursday.

RBNZ Governor Alan Bollard also said inflation remains under control.

The Official Cash Rate has been 2.50 percent since March 2011.

"The domestic economy is showing signs of recovery. Housing market activity continues to increase and a recovery in building activity appears to be underway, as forecast," said Ballard's statement. "That recovery will strengthen as repairs and reconstruction in Canterbury pick up later in the year."

Bollard called the current 2.5 percent rate for the OCR "appropriate."

"Inflation is restrained and is expected to stay near the middle of the bank's target range," he said.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After turning in a strong performance last week, stocks may show a lack of direction in early trading on Monday. The major index futures are currently pointing to a roughly flat open for the markets, with the Dow futures down by just 1 point. Healthcare products maker Kimberly-Clark Corp. (KMB) said that its first-quarter net income attributable to the company rose to $538 million from the prior year's $531 million, with earnings per share improving to $1.41 from $1.36 last year. Adjusted earnings for the quarter were $1.48 per share,... Chipmaker Advanced Micro Devices Inc. said Thursday after the markets closed that its first quarter loss narrowed from last year, helped by strong revenue growth in its graphics and visual solutions business. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.